Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors
- Conditions
- Registration Number
- NCT06682039
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Brief Summary
This clinical trial studies how well attention bias modification (ABM) improves anxiety in adolescent and young adult (AYA) cancer survivors. Cancer-related anxiety is the most prevalent mental health problem affecting AYA cancer survivors. Cancer-related anxiety is associated with long-term negative outcomes such as poor quality of life, depression, distres...
- Detailed Description
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients engage in ABM over 10 minutes twice a week (BIW) and respond daily to text messaging prompts to complete gratitude/savoring activity for 4 weeks.
...
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
- Age 15-29 years
- Diagnosis of cancer malignancy
- Received active/curative cancer treatment at Seattle Children's Hospital (SCH), or other study referring site (e.g. St. Jude)
- Currently off active/curative cancer treatment
- Patient able to understand/read/write English language
- Cognitively able to participate in ABM intervention and complete surveys
- Patient has access to smartphone able to send and receive text messages
- Patient has access to computer or smartphone for Inquisit program
- Patients on active/curative cancer treatment
- Cognitively or physically unable to participate in ABM intervention and surveys
- Patients who cannot understand/read/write English will be excluded from the research because the ABM intervention is currently only available in English
- Furthermore, patients who do not have access to technology (smartphone/computer) will be excluded from the study as this technology is absolutely required to engage in the study intervention
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Clinic recruitment rates Up to 4 weeks post-intervention Feasibility will be assessed via clinic recruitment rates, defined as (number \[#\] of adolescent and young adults \[AYAs\] who enroll in the study) / (total # of AYAs screened as eligible). Attention bias modification (ABM) will be considered feasible with ≥ 50% enrollment.
Retention rates Up to 4 weeks post-intervention Uptake will be assessed via retention rates, defined as (# of AYAs who complete 4-week treatment duration of ABM) / (# of AYAs who enroll in the study). ABM will be considered feasible with ≥ 70% retention.
Patient acceptability of ABM: Client Satisfaction Questionnaire (CSQ-8) At 4 weeks post intervention Will be assessed using the Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item questionnaire used to assess level of satisfaction with care. Items are scored on a Likert scale from 1 (low satisfaction) to 4 (high satisfaction) with different descriptors for each response point. Total scores range from 8 to 32, with higher scores indicating grea...
Patient acceptability of ABM: System Usability Scale (SUS) At 4 weeks post intervention Will be assessed using the System Usability Scale (SUS). The SUS is a well-validated and widely used 10-item scale to evaluate the perceived usability of digital interventions. Items are rated on a 5-point Likert scale for a total score ranging from 0-100, and scores ≥ 70 considered adequate usability.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
🇺🇸Seattle, Washington, United States